Home › Glycogen Storage Disease Type II › Arizona › Phoenix
Glycogen Storage Disease Type II clinical trials in Phoenix, AZ
3 studies for Glycogen Storage Disease Type II are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)
RecruitingPhase 1/2
- Barrow Neurological Institute, Phoenix
Pompe Disease Registry Protocol
RecruitingObservational study
- Barrow Neurological Institute- Site Number : 840087, Phoenix
- Phoenix Children's Hospital- Site Number : 840003, Phoenix
Pompe Pregnancy Sub-Registry
RecruitingObservational study
- Barrow Neurol Group- Site Number : 840087, Phoenix
Glycogen Storage Disease Type II trials in other cities
- Durham, NC8 studies
- Arlington, VA5 studies
- St. Louis, MO5 studies
- Irvine, CA5 studies
- Atlanta, GA4 studies
- New York City, NY4 studies
- Pittsburgh, PA4 studies
- Philadelphia, PA4 studies
- Indianapolis, IN3 studies
- Jacksonville, FL3 studies
- Cincinnati, OH3 studies
Other studies in Phoenix
- Breast Cancer25 studies
- Colorectal Cancer25 studies
- Obesity22 studies
- Non-Small Cell Lung Cancer20 studies
- Metastatic Cancer20 studies
- Heart Failure18 studies
- Prostate Cancer17 studies
- Cancer (all types)17 studies
- Multiple Myeloma16 studies
- Pancreatic Cancer16 studies
- Cardiovascular Disease16 studies
- Alzheimer's Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.